Pages that link to "Q72182658"
Jump to navigation
Jump to search
The following pages link to Pituitary dwarfism with high serum levels of growth hormone (Q72182658):
Displaying 37 items.
- Characterization of the human growth hormone receptor gene and demonstration of a partial gene deletion in two patients with Laron-type dwarfism (Q24339618) (← links)
- Regulation of Serum Insulin-Like Growth Factors and Their Binding Proteins in Ecuadorean Patients with Growth Hormone Receptor Dysfunction (Growth Hormone Insensitivity) (Q33269806) (← links)
- Classic Case Report of Donohue Syndrome (Leprechaunism; OMIM *246200): The Impact of Consanguineous Mating (Q33429987) (← links)
- Growth curves for Laron syndrome (Q33623527) (← links)
- Long-lived crowded-litter mice exhibit lasting effects on insulin sensitivity and energy homeostasis (Q33701511) (← links)
- Insulin-like growth factor 1 (IGF-1): a growth hormone (Q33918809) (← links)
- Physiology and disorders of the growth hormone receptor (GHR) and GH-GHR signal transduction (Q33975039) (← links)
- Growth hormone response in fetal alcohol syndrome (Q34989678) (← links)
- Effect of human growth hormone treatment for 1 to 7 years on growth of 100 children, with growth hormone deficiency, low birthweight, inherited smallness, Turner's syndrome, and other complaints (Q35149331) (← links)
- An update on Laron syndrome (Q35628459) (← links)
- The ontogenesis of human fetal hormones. I. Growth hormone and insulin (Q35898518) (← links)
- Somatotropic signaling: trade-offs between growth, reproductive development, and longevity (Q37158512) (← links)
- Primary somatomedin deficiency: Case report (Q39534183) (← links)
- Somatomedin-1 (insulin-like growth factor-I) in clinical use. Facts and potential (Q40485543) (← links)
- The insulin‐like growth factor‐I/binding protein axis: physiology, pathophysiology and therapeutic manipulation (Q40492402) (← links)
- Involvement of brain catecholamines and acetylcholine in growth hormone hypersecretory states. Pathophysiological, diagnostic and therapeutic implications (Q40961269) (← links)
- The spectrum of growth-hormone insensitivity (Q41560998) (← links)
- Growth Hormone's Effect on Adipose Tissue: Quality versus Quantity. (Q41573026) (← links)
- Pseudopituitary dwarfism due to resistance to somatomedin: a new syndrome (Q42445060) (← links)
- Serum profiles of insulin‐like growth factors and their binding proteins in adults with growth hormone receptor deficiency treated with insulin like growth factor I (Q46233988) (← links)
- Laron's dwarfism: Studies on the nature of the defect (Q47987434) (← links)
- Mexican case report of a never-treated Laron syndrome patient evolving to metabolic syndrome, type 2 diabetes, and stroke. (Q48275533) (← links)
- Laron dwarfism: Growth and immunoreactive insulin following treatment with human growth hormone (Q48399665) (← links)
- Renal function in Laron syndrome patients treated by insulin-like growth factor-I (Q51592816) (← links)
- Identification of two novel mutations in the human growth hormone receptor gene (Q54745743) (← links)
- Pituitary dwarfism and size of gonads (Q55527764) (← links)
- Approximate confidence limits for the concentration of insulin in radioimmunoassay (Q69783048) (← links)
- Pseudohypopituitary dwarfism with normal plasma growth hormone and low serum sulfation factor (Q70342016) (← links)
- Short stature and its treatment (Q70387074) (← links)
- Occurrence of four types of growth hormone-related dwarfism in Israeli communities (Q70906460) (← links)
- Familial dwarfism with high IR-GH: Report of two affected sibs with genetic and epidemiologic considerations (Q71084019) (← links)
- Puberty in Laron type dwarfism (Q71297518) (← links)
- Radiographic abnormalities in Laron dwarfism (Q72357488) (← links)
- Development of hyperandrogenism during treatment with insulin‐like growth factor‐I (IGF‐I) in female patients with Laron syndrome (Q74332746) (← links)
- Impact of Pituitary Autoimmunity and Genetic Disorders on Growth Hormone Deficiency in Children and Adults (Q89860153) (← links)
- A 42-Year-Old Woman with Untreated Growth Hormone Insensitivity, Diabetic Retinopathy, and Gene Sequencing Identifies a Variant of Laron Syndrome (Q91999330) (← links)
- Significance of Direct Confirmation of Growth Hormone Insensitivity for the Diagnosis of Primary IGF-I Deficiency (Q92809556) (← links)